NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In Thousands, Except Share Data)
March 31, June 30,
2008 2008
----------- -----------
ASSETS
Current assets:
Cash and cash equivalents $ 4,657 $ 5,209
Restricted cash 196 201
Accounts receivable 357 314
Inventories, net 2,827 2,875
Other current assets 1,740 1,103
----------- -----------
Total current assets 9,777 9,702
Property and equipment, net 1,363 1,343
Goodwill 1,764 1,764
Intangible assets, net 2,400 2,200
Restricted cash 4,356 3,766
Deferred tax assets 196 187
Other assets 2,204 2,002
----------- -----------
Total assets $ 22,060 $ 20,964
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 1,879 $ 1,472
Income taxes payable 412 391
Accrued distributor commissions 1,646 1,512
Other accrued expenses 3,276 2,980
Deferred revenue 2,570 2,598
Current portion of convertible debentures, net
of discount of $382 and $541 at March 31,
2008 and June 30, 2008, respectively 503 876
Other current liabilities 3,147 3,362
----------- -----------
Total current liabilities 13,433 13,191
Convertible debentures, net of discount of $3,365
and $2,833 at March 31, 2008 and June 30, 2008,
respectively - -
----------- -----------
Total liabilities 13,433 13,191
Commitments and contingencies
Minority interest 37 37
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000
shares authorized; 1,761,900 shares
designated Series A convertible preferred
stock, 138,400 shares issued and outstanding
at March 31, 2008 and June 30, 2008,
aggregate liquidation value of $254 124 124
Common stock, $0.001 par value; 50,000,000
shares authorized; 10,347,126 and 10,359,626
shares issued and outstanding at March 31,
2008 and June 30, 2008, respectively 10 10
Additional paid-in capital 79,322 79,451
Accumulated deficit (71,697) (72,766)
Accumulated other comprehensive income:
Foreign currency translation adjustments 831 917
----------- -----------
Total stockholders' equity 8,590 7,736
----------- -----------
Total liabilities and stockholders' equity $ 22,060 $ 20,964
=========== ===========
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In Thousands, Except Per Share Data)
Three Months Ended
------------------------
March 31, June 30,
2008 2008
----------- -----------
Net sales $ 11,395 $ 12,323
Cost of sales 3,090 3,445
----------- -----------
Gross profit 8,305 8,878
Operating expenses:
Distributor commissions 3,997 4,600
Selling, general and administrative expenses
(including stock-based compensation expense
of $164 and $129 during the three months
ended March 31, 2008 and June 30, 2008,
respectively) 4,596 4,272
Depreciation and amortization 386 366
Impairment of long-lived assets 24 4
----------- -----------
Total operating expenses 9,003 9,242
----------- -----------
Loss from operations (698) (364)
Other income:
Gain (loss) on foreign exchange 371 (118)
Interest income 35 33
Interest expense (including amortization of
debt issuance costs and accretion of debt
discount of $362 and $449 during the three
months ended March 31, 2008 and June 30,
2008, respectively) (387) (556)
Other 8 (22)
----------- -----------
Total other income (expense), net 27 (663)
----------- -----------
Loss before income taxes and minority interest (671) (1,027)
Income tax provision (37) (42)
----------- -----------
Net loss (708) (1,069)
Preferred stock dividends (4) (4)
----------- -----------
Net loss attributable to common stockholders $ (712) $ (1,073)
=========== ===========
Loss per share - basic and diluted $ (0.07) $ (0.11)
=========== ===========
Weighted-average number of shares outstanding 9,567 9,619
=========== ===========
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In Thousands)
Three Months Ended
------------------------
March 31, June 30,
2008 2008
----------- -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (708) $ (1,069)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization of property and
equipment 186 166
Amortization of intangibles 200 200
Amortization of debt issuance costs 62 76
Accretion of debt discount 300 373
Stock-based compensation 164 129
Impairment of long-lived assets 24 4
Changes in assets and liabilities:
Accounts receivable 50 36
Inventories, net 781 (69)
Other current assets (399) 638
Other assets 59 83
Accounts payable (293) (410)
Income taxes payable 18 (16)
Accrued distributor commissions (374) (121)
Other accrued expenses (389) (294)
Deferred revenue (938) 46
Other current liabilities (127) 84
----------- -----------
Net cash used in operating activities (1,384) (144)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment (6) (140)
Decrease in restricted cash 93 614
----------- -----------
Net cash provided by investing activities 87 474
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from debt - 145
----------- -----------
Net cash provided by financing activities - 145
----------- -----------
Effect of exchange rates on cash and cash
equivalents (328) 77
----------- -----------
Net (decrease) increase in cash and cash
equivalents (1,625) 552
CASH AND CASH EQUIVALENTS, beginning of period 6,282 4,657
----------- -----------
CASH AND CASH EQUIVALENTS, end of period $ 4,657 $ 5,209
=========== ===========
Contact Information: Contact: Jean Bono Natural Health Trends Corp.